Point-of-Care Molecular Diagnostics Market 2025 to 2034
Point-of-Care Molecular Diagnostics Market 2025 to 2034
Point-of-Care Molecular Diagnostics Market (By Technology: PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based; By Application: Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other; By Location: OTC, POC; By End Use: Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Others) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 8.95 Bn
Forecast Year, 2034
USD 12.61 Bn
CAGR, 2025 - 2034
3.87%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global point-of-care molecular diagnostics market, valued at USD 8.95B in 2025, is projected to reach USD 12.61B by 2034, growing at a CAGR of 3.87%, driven by rapid adoption of decentralized testing and advanced molecular technologies.
Point-of-Care Molecular Diagnostics Market Size Analysis
Point-of-Care Molecular Diagnostics Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| PCR-based | 4.04 | 4.19 | 4.36 | 4.52 | 4.70 | 4.88 | 5.07 | 5.27 | 5.47 | 5.68 |
| Genetic Sequencing-based | 2.15 | 2.23 | 2.32 | 2.41 | 2.50 | 2.60 | 2.70 | 2.80 | 2.91 | 3.03 |
| Hybridization-based | 1.64 | 1.71 | 1.77 | 1.84 | 1.91 | 1.99 | 2.07 | 2.15 | 2.23 | 2.32 |
| Microarray-based | 1.12 | 1.16 | 1.21 | 1.25 | 1.30 | 1.35 | 1.40 | 1.46 | 1.52 | 1.57 |
Point-of-Care Molecular Diagnostics Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Infectious Diseases | 3.33 | 3.46 | 3.60 | 3.74 | 3.88 | 4.03 | 4.19 | 4.35 | 4.52 | 4.69 |
| Oncology | 1.60 | 1.66 | 1.72 | 1.79 | 1.86 | 1.93 | 2.01 | 2.09 | 2.17 | 2.25 |
| Hematology | 1.26 | 1.31 | 1.36 | 1.41 | 1.47 | 1.52 | 1.58 | 1.64 | 1.71 | 1.77 |
| Prenatal Testing | 1.09 | 1.13 | 1.18 | 1.22 | 1.27 | 1.32 | 1.37 | 1.42 | 1.48 | 1.54 |
| Endocrinology | 0.92 | 0.96 | 0.99 | 1.03 | 1.07 | 1.11 | 1.16 | 1.20 | 1.25 | 1.30 |
| Other | 0.75 | 0.77 | 0.80 | 0.84 | 0.87 | 0.90 | 0.94 | 0.97 | 1.01 | 1.05 |
Point-of-Care Molecular Diagnostics Market Size By Location 2025 to 2034 (USD Billion)
| Location | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| OTC | 3.63 | 3.77 | 3.92 | 4.07 | 4.22 | 4.39 | 4.56 | 4.73 | 4.92 | 5.11 |
| POC | 5.32 | 5.53 | 5.74 | 5.96 | 6.19 | 6.43 | 6.68 | 6.94 | 7.21 | 7.49 |
Point-of-Care Molecular Diagnostics Market Size By End Use 2025 to 2034 (USD Billion)
| End Use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Decentralized Labs | 2.81 | 2.92 | 3.03 | 3.15 | 3.27 | 3.39 | 3.53 | 3.66 | 3.80 | 3.95 |
| Hospitals | 3.03 | 3.15 | 3.27 | 3.39 | 3.53 | 3.66 | 3.80 | 3.95 | 4.10 | 4.26 |
| Homecare | 1.27 | 1.32 | 1.37 | 1.42 | 1.47 | 1.53 | 1.59 | 1.65 | 1.72 | 1.78 |
| Assisted Living Healthcare Facilities | 1.10 | 1.14 | 1.19 | 1.23 | 1.28 | 1.33 | 1.38 | 1.44 | 1.49 | 1.55 |
| Others | 0.75 | 0.77 | 0.80 | 0.84 | 0.87 | 0.90 | 0.94 | 0.97 | 1.01 | 1.05 |
Point-of-Care Molecular Diagnostics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.25 | 3.38 | 3.51 | 3.64 | 3.78 | 3.93 | 4.08 | 4.24 | 4.40 | 4.58 |
| Europe | 2.32 | 2.41 | 2.50 | 2.60 | 2.70 | 2.80 | 2.91 | 3.03 | 3.14 | 3.26 |
| Asia Pacific | 2.08 | 2.16 | 2.25 | 2.33 | 2.43 | 2.52 | 2.62 | 2.72 | 2.82 | 2.93 |
| Latin America | 0.74 | 0.76 | 0.79 | 0.82 | 0.86 | 0.89 | 0.92 | 0.96 | 1.00 | 1.04 |
| Middle East and Africa | 0.56 | 0.58 | 0.60 | 0.63 | 0.65 | 0.68 | 0.70 | 0.73 | 0.76 | 0.79 |
Point-of-Care Molecular Diagnostics Market Size to Surpass USD 12.61 Billion by 2034
The global point-of-care molecular diagnostics market size was calculated at USD 8.95 billion in 2025 and is predicted to attain around USD 12.61 billion by 2034 a CAGR of 3.87%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
